Source: International Congress 2015 – Lung function: waiting to exhale...
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Andriana Papaioannou (Vrilissia, Athens, Greece), Andriana Papaioannou, Yiolanda Herodotou, Ioannis Tomos, Giorgos Skylas, Vasileios Seferlis, Effrosyni Manali, Stelios Loukides, Spyros Papiris. Capacity of using DPIs during COPD exacerbations. Eur Respir J 2015; 46: Suppl. 59, 1585

Member's Comments

No comment yet.

Related content which might interest you: Impact of mucolytic treatment on COPD exacerbations Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation Year: 2013 Management of COPD exacerbations Source: ERS Lung Science Conference 2019 Year: 2019 Evaluation of COPD exacerbations using the EXACT-U Source: Annual Congress 2010 - COPD exacerbation Year: 2010 Real life assessment of inhaler use and acute exacerbations in 2935 COPD patients Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Frequency of COPD exacerbations and severity of COPD Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Breathlessness perception in COPD: Relationship with exacerbation frequency Source: International Congress 2015 – Multidimensional analysis of respiratory problems Year: 2015 Prediction of the duration of hospitilization in acute COPD exacerbations: The AECOPD-F score Source: International Congress 2014 – Monitoring COPD with different biomarkers Year: 2014 Lung function change and exacerbations in patients with COPD in the WISDOM study Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015 Role of comorbidities on mortality in patients hospitalized for COPD exacerbations Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Impact of frequent exacerbations in patients with COPD Source: International Congress 2014 – Clinical presentations Year: 2014 Mukoregulatory drugs in treating COPD Source: International Congress 2014 – Predictors Year: 2014 First dose response to tiotropium in COPD: Impact on dyspnea, lung hyperinflation and distal airways Source: Annual Congress 2013 –COPD drugs: new findings Year: 2013 Modelling exacerbations of COPD Source: Annual Congress 2012 - Modelling respiratory infections: is it the future or the present? Year: 2012 Erdosteine improves airflow in patients with severe exacerbation of COPD (AECOPD) Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Microbiological indicators from sputum of patients with exacerbation of COPD Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants Year: 2015 Monitoring catalase activity in COPD exacerbations Source: International Congress 2016 – Airway biomarkers Year: 2016 Acute exacerbations of COPD Source: Eur Respir Monogr 2016; 74: 48-65 Year: 2016 Pneumonia risk in COPD patients on long term inhaled corticosteroids – Data from the European COPD audit<% Source: Annual Congress 2013 –Guidelines and exacerbations Year: 2013 Impact of bronchiectasis on duration of hospitalization in patients with exacerbations of COPD Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations Year: 2015 Tele-monitoring intervention on COPD exacerbations Source: International Congress 2016 – Novel approaches for pulmonary rehabilitation in chronic lung diseases Year: 2016